nach oben

Current Diabetes Reports

Erschienen in:

01.07.2016 | Pediatric Type 2 Diabetes (PS Zeitler, Section Editor)

Cardiac Abnormalities in Youth with Obesity and Type 2 Diabetes

verfasst von: Fida Bacha, Samuel S. Gidding

Erschienen in: Current Diabetes Reports | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

Childhood obesity has been linked to cardiovascular disease (CVD) risk in adulthood. Of great concern is the expected increase in the population’s CVD burden in relation to childhood obesity. This is compounded by the risk related to chronic hyperglycemia exposure in youth with type 2 diabetes. We herein provide an overview of the spectrum of early cardiovascular disease manifestation in youth with obesity and type 2 diabetes, in particular abnormalities in cardiac structure and function. Cardiac remodeling and adverse target organ damage is already evident in the pediatric age group in children with obesity and type 2 diabetes. This supports the importance of intensifying obesity prevention efforts and early intervention to treat comorbidities of obesity in the pediatric age group to prevent cardiac events in early adulthood.

Ogden CL, Carroll MD, Kit BK, et al. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA. 2014;311(8):806–14.PubMedPubMedCentralCrossRef

Dabelea D, Mayer-Davis EJ, Saydah S, et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. Jama. 2014;311(17):1778–86.PubMedPubMedCentralCrossRef

Mahoney LT, Burns TL, Stanford W, et al. Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: the Muscatine study. J Am Coll Cardiol. 1996;27(2):277–84.PubMedCrossRef

Toprak A, Wang H, Chen W, et al. Relation of childhood risk factors to left ventricular hypertrophy (eccentric or concentric) in relatively young adulthood (from the Bogalusa Heart study). Am J Cardiol. 2008;101(11):1621–5.PubMedCrossRef

Juonala M, Magnussen CG, Venn A, et al. Influence of age on associations between childhood risk factors and carotid intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns study, the Childhood Determinants of Adult Health study, the Bogalusa Heart study, and the Muscatine study for the International Childhood Cardiovascular Cohort (i3C) Consortium. Circulation. 2010;122(24):2514–20.PubMedCrossRef

McGill Jr HC, McMahan CA, Herderick EE, et al. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation. 2002;105(23):2712–8.PubMedCrossRef

Bibbins-Domingo K, Coxson P, Pletcher MJ, et al. Adolescent overweight and future adult coronary heart disease. N Engl J Med. 2007;357(23):2371–9.PubMedCrossRef

Fagot-Campagna A. Emergence of type 2 diabetes mellitus in children: epidemiological evidence. J Pediatric Endocrinol Metab JPEM. 2000;13 Suppl 6:1395–402.PubMed

Rosenbloom AL, Joe JR, Young RS, et al. Emerging epidemic of type 2 diabetes in youth. Diabetes Care. 1999;22(2):345–54.PubMedCrossRef

10.

Jousilahti P, Tuomilehto J, Vartiainen E, et al. Body weight, cardiovascular risk factors, and coronary mortality. 15-year follow-up of middle-aged men and women in eastern Finland. Circulation. 1996;93(7):1372–9.PubMedCrossRef

11.•

Mitchell AB, Cole JW, McArdle PF, et al. Obesity increases risk of ischemic stroke in young adults. Stroke J Cerebral Circulation. 2015;46(6):1690–2. Relationship of obesity to the risk of stroke.CrossRef

12.

Wilhelmsen L, Rosengren A, Eriksson H, et al. Heart failure in the general population of men—morbidity, risk factors and prognosis. J Intern Med. 2001;249(3):253–61.PubMedCrossRef

13.

He J, Ogden LG, Bazzano LA, et al. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med. 2001;161(7):996–1002.PubMedCrossRef

14.

Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347(5):305–13.PubMedCrossRef

15.

Emerging Risk Factors C, Wormser D, Kaptoge S, Di Angelantonio E, et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet. 2011;377(9771):1085–95.CrossRef

16.

Emerging Risk Factors C, Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–22.CrossRef

17.

Gidding SS. Noninvasive cardiac imaging: implications for risk assessment in adolescents and young adults. Ann Med. 2008;40(7):506–13.PubMedCrossRef

18.

May AL, Kuklina EV, Yoon PW. Prevalence of cardiovascular disease risk factors among US adolescents, 1999–2008. Pediatrics. 2012;129(6):1035–41.PubMedCrossRef

19.

Sorof JM, Poffenbarger T, Franco K, et al. Isolated systolic hypertension, obesity, and hyperkinetic hemodynamic states in children. J Pediatr. 2002;140(6):660–6.PubMedCrossRef

20.

Maggio AB, Aggoun Y, Marchand LM, et al. Associations among obesity, blood pressure, and left ventricular mass. J Pediatr. 2008;152(4):489–93.PubMedCrossRef

21.

Kit BK, Kuklina E, Carroll MD, et al. Prevalence of and trends in dyslipidemia and blood pressure among US children and adolescents, 1999–2012. JAMA Pediatrics. 2015;169(3):272–9.PubMedCrossRef

22.

Pinhas-Hamiel O, Zeitler P. Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet. 2007;369(9575):1823–31.PubMedCrossRef

23.

Petitti DB, Imperatore G, Palla SL, et al. Serum lipids and glucose control: the SEARCH for Diabetes in Youth study. Arch Pediatrics Adolescent Med. 2007;161(2):159–65.CrossRef

24.

Eppens MC, Craig ME, Cusumano J, et al. Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care. 2006;29(6):1300–6.PubMedCrossRef

25.

Constantino MI, Molyneaux L, Limacher-Gisler F, et al. Long-term complications and mortality in young-onset diabetes: type 2 diabetes is more hazardous and lethal than type 1 diabetes. Diabetes Care. 2013;36(12):3863–9.PubMedPubMedCentralCrossRef

26.

Bacha F, Gungor N, Lee S, et al. In vivo insulin sensitivity and secretion in obese youth: what are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes? Diabetes Care. 2009;32(1):100–5.PubMedPubMedCentralCrossRef

27.

Tfayli H, Bacha F, Gungor N, et al. Phenotypic type 2 diabetes in obese youth: insulin sensitivity and secretion in islet cell antibody-negative versus -positive patients. Diabetes. 2009;58(3):738–44.PubMedPubMedCentralCrossRef

28.

Evans JL, Goldfine ID, Maddux BA, et al. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev. 2002;23(5):599–622.PubMedCrossRef

29.

Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107(9):1058–70.PubMedPubMedCentralCrossRef

30.•

Group TS, Zeitler P, Hirst K, et al. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med. 2012;366(24):2247–56. Primary outcome data of the TODAY study highlighting aggressive course of T2DM in youth.CrossRef

31.

Group TS, Zeitler P, Epstein L, et al. Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes. Pediatr Diabetes. 2007;8(2):74–87.CrossRef

32.••

Group TS. Lipid and inflammatory cardiovascular risk worsens over 3 years in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care. 2013;36(6):1758–64. Worsening of dyslipidemia and inflammation over time in youth with T2DM in TODAY.CrossRef

33.••

Group TS. Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care. 2013;36(6):1735–41. Rapid increase in the rate of microalbuminuria and hypertension in youth with T2DM in TODAY.CrossRef

34.

Kriska A, Delahanty L, Edelstein S, et al. Sedentary behavior and physical activity in youth with recent onset of type 2 diabetes. Pediatrics. 2013;131(3):e850–6.PubMedPubMedCentralCrossRef

35.

Baker JL, Olsen LW, Sorensen TI. Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med. 2007;357(23):2329–37.PubMedPubMedCentralCrossRef

36.

Tirosh A, Shai I, Afek A, et al. Adolescent BMI trajectory and risk of diabetes versus coronary disease. N Engl J Med. 2011;364(14):1315–25.PubMedCrossRef

37.

Li X, Li S, Ulusoy E, et al. Childhood adiposity as a predictor of cardiac mass in adulthood: the Bogalusa Heart study. Circulation. 2004;110(22):3488–92.PubMedCrossRef

38.

Juhola J, Magnussen CG, Viikari JS, et al. Tracking of serum lipid levels, blood pressure, and body mass index from childhood to adulthood: the Cardiovascular Risk in Young Finns study. J Pediatr. 2011;159(4):584–90.PubMedCrossRef

39.

Urbina EM, Williams RV, Alpert BS, et al. Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. Hypertension. 2009;54(5):919–50.PubMedCrossRef

40.

Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55(13):1318–27.PubMedCrossRef

41.

Lorenz MW, Markus HS, Bots ML, et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115(4):459–67.PubMedCrossRef

42.

Urbina EM, Bean JA, Daniels SR, et al. Overweight and hyperinsulinemia provide individual contributions to compromises in brachial artery distensibility in healthy adolescents and young adults: brachial distensibility in children. J Am Soc Hypertension JASH. 2007;1(3):200–7.CrossRef

43.

Gungor N, Bacha F, Saad R, et al. Youth type 2 diabetes: insulin resistance, beta-cell failure, or both? Diabetes Care. 2005;28(3):638–44.PubMedPubMedCentralCrossRef

44.

Urbina EM, Kimball TR, Khoury PR, et al. Increased arterial stiffness is found in adolescents with obesity or obesity-related type 2 diabetes mellitus. J Hypertens. 2010;28(8):1692–8.PubMedPubMedCentralCrossRef

45.

Shah AS, Dolan LM, Kimball TR, et al. Influence of duration of diabetes, glycemic control, and traditional cardiovascular risk factors on early atherosclerotic vascular changes in adolescents and young adults with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2009;94(10):3740–5.PubMedPubMedCentralCrossRef

46.

Naylor LH, Green DJ, Jones TW, et al. Endothelial function and carotid intima-medial thickness in adolescents with type 2 diabetes mellitus. J Pediatr. 2011;159(6):971–4.PubMedCrossRef

47.••

Bacha F, Edmundowicz D, Sutton-Tyrell K, et al. Coronary artery calcification in obese youth: what are the phenotypic and metabolic determinants? Diabetes Care. 2014;37(9):2632–9. Determinants of pulse wave velocity, intima-media thickness and coronary calcification in obese youth with and without T2DM.PubMedPubMedCentralCrossRef

48.

Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29(19):2388–442.PubMedCrossRef

49.

Mor-Avi V, Lang RM, Badano LP, et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. Eur J Echocardiograp J Work Group Echocardiograp Eur Soc Cardiol. 2011;12(3):167–205.CrossRef

50.

de Simone G, Devereux RB, Roman MJ, et al. Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension. 1994;23(5):600–6.PubMedCrossRef

51.

Daniels SR, Kimball TR, Morrison JA, et al. Indexing left ventricular mass to account for differences in body size in children and adolescents without cardiovascular disease. Am J Cardiol. 1995;76(10):699–701.PubMedCrossRef

52.

de Simone G, Devereux RB, Daniels SR, et al. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol. 1995;25(5):1056–62.PubMedCrossRef

53.

Daniels SR, Loggie JM, Khoury P, et al. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation. 1998;97(19):1907–11.PubMedCrossRef

54.

de Simone G, Daniels SR, Kimball TR, et al. Evaluation of concentric left ventricular geometry in humans: evidence for age-related systematic underestimation. Hypertension. 2005;45(1):64–8.PubMedCrossRef

55.

Ganau A, Saba PS, Roman MJ, et al. Ageing induces left ventricular concentric remodelling in normotensive subjects. J Hypertens. 1995;13(12 Pt 2):1818–22.PubMed

56.

Daniels SR, Meyer RA, Liang YC, et al. Echocardiographically determined left ventricular mass index in normal children, adolescents and young adults. J Am Coll Cardiol. 1988;12(3):703–8.PubMedCrossRef

57.••

Levitt Katz L, Gidding SS, Bacha F, et al. Alterations in left ventricular, left atrial, and right ventricular structure and function to cardiovascular risk factors in adolescents with type 2 diabetes participating in the TODAY clinical trial. Pediatr Diabetes. 2015;16(1):39–47. Echocardiographic findings in youth with T2DM in relation to obesity, blood pressure, sex and race-ethnicity in TODAY.PubMedCrossRef

58.

Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 1992;19(7):1550–8.PubMedCrossRef

59.

Muiesan ML, Salvetti M, Monteduro C, et al. Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension. 2004;43(4):731–8.PubMedCrossRef

60.

D'Hooge J, Heimdal A, Jamal F, et al. Regional strain and strain rate measurements by cardiac ultrasound: principles, implementation and limitations. Eur J Echocardiograp J Work Group Echocardiograp Eur Soc Cardiol. 2000;1(3):154–70.CrossRef

61.

Wong CY, O'Moore-Sullivan T, Leano R, et al. Alterations of left ventricular myocardial characteristics associated with obesity. Circulation. 2004;110(19):3081–7.PubMedCrossRef

62.

De Boeck BW, Cramer MJ, Oh JK, et al. Spectral pulsed tissue Doppler imaging in diastole: a tool to increase our insight in and assessment of diastolic relaxation of the left ventricle. Am Heart J. 2003;146(3):411–9.PubMedCrossRef

63.

Leite-Moreira AF. Current perspectives in diastolic dysfunction and diastolic heart failure. Heart. 2006;92(5):712–8.PubMedPubMedCentralCrossRef

64.

Rider OJ, Francis JM, Ali MK, et al. Effects of catecholamine stress on diastolic function and myocardial energetics in obesity. Circulation. 2012;125(12):1511–9.PubMedCrossRef

65.

de Jonge LL, van Osch-Gevers L, Willemsen SP, et al. Growth, obesity, and cardiac structures in early childhood: the Generation R study. Hypertension. 2011;57(5):934–40.PubMedCrossRef

66.

Daniels SR, Kimball TR, Morrison JA, et al. Effect of lean body mass, fat mass, blood pressure, and sexual maturation on left ventricular mass in children and adolescents. Statistical, biological, and clinical significance. Circulation. 1995;92(11):3249–54.PubMedCrossRef

67.

Urbina EM, Gidding SS, Bao W, et al. Effect of body size, ponderosity, and blood pressure on left ventricular growth in children and young adults in the Bogalusa Heart study. Circulation. 1995;91(9):2400–6.PubMedCrossRef

68.

Sivanandam S, Sinaiko AR, Jacobs Jr DR, et al. Relation of increase in adiposity to increase in left ventricular mass from childhood to young adulthood. Am J Cardiol. 2006;98(3):411–5.PubMedCrossRef

69.

Chinali M, de Simone G, Roman MJ, et al. Impact of obesity on cardiac geometry and function in a population of adolescents: the Strong Heart study. J Am Coll Cardiol. 2006;47(11):2267–73.PubMedCrossRef

70.

Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart study. N Engl J Med. 1990;322(22):1561–6.PubMedCrossRef

71.

Armstrong AC, Gidding S, Gjesdal O, et al. LV mass assessed by echocardiography and CMR, cardiovascular outcomes, and medical practice. J Am Coll Cardiol Img. 2012;5(8):837–48.CrossRef

72.•

Armstrong AC, Jacobs Jr DR, Gidding SS, et al. Framingham score and LV mass predict events in young adults: CARDIA study. Int J Cardiol. 2014;172(2):350–5. Relationship of LV mass to CV events in CARDIA.PubMedPubMedCentralCrossRef

73.

Devereux RB, Roman MJ, Paranicas M, et al. Impact of diabetes on cardiac structure and function: the strong heart study. Circulation. 2000;101(19):2271–6.PubMedCrossRef

74.

Ilercil A, Devereux RB, Roman MJ, et al. Relationship of impaired glucose tolerance to left ventricular structure and function: the Strong Heart study. Am Heart J. 2001;141(6):992–8.PubMedCrossRef

75.

Palmieri V, Bella JN, Arnett DK, et al. Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study. Circulation. 2001;103(1):102–7.PubMedCrossRef

76.•

Gidding SS, Liu K, Colangelo LA, et al. Longitudinal determinants of left ventricular mass and geometry: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Circulation Cardiovasc Imaging. 2013;6(5):769–75. Prevalence of abnormal LV mass and geometry increased from young adulthood to middle age In CARDIA and was related to cardiovascular risk factors at baseline and change in these risk factors.CrossRef

77.

Beljic T, Miric M. Improved metabolic control does not reverse left ventricular filling abnormalities in newly diagnosed non-insulin-dependent diabetes patients. Acta Diabetol. 1994;31(3):147–50.PubMedCrossRef

78.

Schillaci G, Pasqualini L, Verdecchia P, et al. Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. J Am Coll Cardiol. 2002;39(12):2005–11.PubMedCrossRef

79.

From AM, Scott CG, Chen HH. The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study. J Am Coll Cardiol. 2010;55(4):300–5.PubMedCrossRef

80.

Tsang TS, Abhayaratna WP, Barnes ME, et al. Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter? J Am Coll Cardiol. 2006;47(5):1018–23.PubMedCrossRef

81.

Moller JE, Hillis GS, Oh JK, et al. Left atrial volume: a powerful predictor of survival after acute myocardial infarction. Circulation. 2003;107(17):2207–12.PubMedCrossRef

82.

Friberg P, Allansdotter-Johnsson A, Ambring A, et al. Increased left ventricular mass in obese adolescents. Eur Heart J. 2004;25(11):987–92.PubMedCrossRef

83.

Ayer JG, Sholler GF, Celermajer DS. Left atrial size increases with body mass index in children. Int J Cardiol. 2010;141(1):61–7.PubMedCrossRef

84.

Yu JJ, Yeom HH, Chung S, et al. Left atrial diameters in overweight children with normal blood pressure. J Pediatr. 2006;148(3):321–5.PubMedCrossRef

85.

Dhuper S, Abdullah RA, Weichbrod L, et al. Association of obesity and hypertension with left ventricular geometry and function in children and adolescents. Obesity. 2011;19(1):128–33.PubMedCrossRef

86.

Sorof JM, Cardwell G, Franco K, et al. Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension. 2002;39(4):903–8.PubMedCrossRef

87.

Avelar E, Cloward TV, Walker JM, et al. Left ventricular hypertrophy in severe obesity: interactions among blood pressure, nocturnal hypoxemia, and body mass. Hypertension. 2007;49(1):34–9.PubMedCrossRef

88.

Whalley GA, Gusso S, Hofman P, et al. Structural and functional cardiac abnormalities in adolescent girls with poorly controlled type 2 diabetes. Diabetes Care. 2009;32(5):883–8.PubMedPubMedCentralCrossRef

89.

Daniels SR, Witt SA, Glascock B, et al. Left atrial size in children with hypertension: the influence of obesity, blood pressure, and left ventricular mass. J Pediatr. 2002;141(2):186–90.PubMedCrossRef

90.

Ippisch HM, Inge TH, Daniels SR, et al. Reversibility of cardiac abnormalities in morbidly obese adolescents. J Am Coll Cardiol. 2008;51(14):1342–8.PubMedCrossRef

91.

Shah AS, Khoury PR, Dolan LM, et al. The effects of obesity and type 2 diabetes mellitus on cardiac structure and function in adolescents and young adults. Diabetologia. 2011;54(4):722–30.PubMedCrossRef

92.

Cerutti F, Rabbia F, Rabbone I, et al. Impairment of cardiovascular autonomic pattern in obese adolescents with type 2 diabetes mellitus. J Endocrinol Investig. 2010;33(8):539–43.CrossRef

93.

Mehta SK, Holliday C, Hayduk L, et al. Comparison of myocardial function in children with body mass indexes >/=25 versus those <25 kg/m². Am J Cardiol. 2004;93(12):1567–9.PubMedCrossRef

94.

Ingul CB, Tjonna AE, Stolen TO, et al. Impaired cardiac function among obese adolescents: effect of aerobic interval training. Arch Pediatrics Adolescent Med. 2010;164(9):852–9.CrossRef

95.

Di Salvo G, Pacileo G, Del Giudice EM, et al. Abnormal myocardial deformation properties in obese, non-hypertensive children: an ambulatory blood pressure monitoring, standard echocardiographic, and strain rate imaging study. Eur Heart J. 2006;27(22):2689–95.PubMedCrossRef

96.

Lorch SM, Sharkey A. Myocardial velocity, strain, and strain rate abnormalities in healthy obese children. J Cardiometab Syndrome. 2007;2(1):30–4.CrossRef

97.

Schuster I, Karpoff L, Perez-Martin A, et al. Cardiac function during exercise in obese prepubertal boys: effect of degree of obesity. Obesity. 2009;17(10):1878–83.PubMedCrossRef

98.

Bhattacharjee R, Kheirandish-Gozal L, Pillar G, et al. Cardiovascular complications of obstructive sleep apnea syndrome: evidence from children. Prog Cardiovasc Dis. 2009;51(5):416–33.PubMedCrossRef

99.

Amin RS, Kimball TR, Kalra M, et al. Left ventricular function in children with sleep-disordered breathing. Am J Cardiol. 2005;95(6):801–4.PubMedCrossRef

100.

Pinto TE, Gusso S, Hofman PL, et al. Systolic and diastolic abnormalities reduce the cardiac response to exercise in adolescents with type 2 diabetes. Diabetes Care. 2014;37(5):1439–46.PubMedCrossRef

101.

Nadeau KJ, Zeitler PS, Bauer TA, et al. Insulin resistance in adolescents with type 2 diabetes is associated with impaired exercise capacity. J Clin Endocrinol Metab. 2009;94(10):3687–95.PubMedPubMedCentralCrossRef

102.

Klingbeil AU, Schneider M, Martus P, et al. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med. 2003;115(1):41–6.PubMedCrossRef

103.

Fagard RH, Celis H, Thijs L, et al. Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies. Hypertension. 2009;54(5):1084–91.PubMedCrossRef

104.

Wang JG, Staessen JA, Li Y, et al. Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials. Stroke J Cerebral Circulation. 2006;37(7):1933–40.CrossRef

105.•

Byrkjeland R, Stensaeth KH, Anderssen S, et al. Effects of exercise training on carotid intima-media thickness in patients with type 2 diabetes and coronary artery disease. Influence of carotid plaques. Cardiovasc Diabetol. 2016;15(1):13. One year of exercise training in patients with type 2 diabetes and CAD; a beneficial effect of exercise training on cIMT progression was demonstrated in those who did not have plaques. This highlights the importance of early intervention.PubMedPubMedCentralCrossRef

106.

Crouse 3rd JR, Raichlen JS, Riley WA, et al. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. Jama. 2007;297(12):1344–53.PubMedCrossRef

107.

Watts K, Beye P, Siafarikas A, et al. Exercise training normalizes vascular dysfunction and improves central adiposity in obese adolescents. J Am Coll Cardiol. 2004;43(10):1823–7.PubMedCrossRef

108.

Farpour-Lambert NJ, Aggoun Y, Marchand LM, et al. Physical activity reduces systemic blood pressure and improves early markers of atherosclerosis in pre-pubertal obese children. J Am Coll Cardiol. 2009;54(25):2396–406.PubMedCrossRef

109.

Zeybek C, Aktuglu-Zeybek C, Onal H, et al. Right ventricular subclinical diastolic dysfunction in obese children: the effect of weight reduction with a low-carbohydrate diet. Pediatr Cardiol. 2009;30(7):946–53.PubMedCrossRef

110.

Millen A, Norton G, Avidon I, et al. Effects of short-term exercise training on tissue Doppler indices of left ventricular diastolic function in overweight and obese individuals. J Sports Sci. 2014;32(5):487–99.PubMedCrossRef

111.

Bacha F GS, Pyle L, Katz L, Kriska A, Nadeau K. Relationship of echocardiogram (ECHO) to cardiorespiratory fitness (CRF) and body composition in youth with type 2 diabetes (T2D) in TODAY. Diabetes. 2014:164-OR.

112.

Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–89.PubMedCrossRef

Titel: Cardiac Abnormalities in Youth with Obesity and Type 2 Diabetes
verfasst von: Fida Bacha
Samuel S. Gidding
Publikationsdatum: 01.07.2016
Verlag: Springer US
Erschienen in: Current Diabetes Reports / Ausgabe 7/2016
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI: https://doi.org/10.1007/s11892-016-0750-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2016

Will the Affordable Care Act (ACA) Improve Racial/Ethnic Disparity of Eye Examination Among US Working-Age Population with Diabetes?

Genetics of Type 2 Diabetes: the Power of Isolated Populations

Putting the Genome in Context: Gene-Environment Interactions in Type 2 Diabetes

Use of Gaming in Self-Management of Diabetes in Teens

Social Support for Diabetes Self-Management via eHealth Interventions